Houston's life sciences market was waiting for demand to catch up to new supply. Now, threats to federal research funding ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

DP_Houston 2 (Paredes, Altuve, Walker; Peña, Walker). Inherited runners-scored_Ort 1-0. HBP_Littell (Peña), Okert (Mead). WP_Littell.

According to the National Weather Service in Dallas/Fort Worth, Memorial Day could be a wash out, with thunderstorms and hail ...

Shares rose in Asia on Wednesday while oil prices jumped more than $1.20 a barrel following a report that Israel may be ...